Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disorder marked by the gradual loss of motor neurons, leading to significant disability and eventual death. Despite ongoing research, there are still limited treatment options, underscoring the need for a deeper understanding of the disease’s complex mechanisms and the identification of new therapeutic targets. This review provides a thorough examination of ALS, covering its epidemiology, pathology, and clinical features. It investigates the key molecular mechanisms, such as protein aggregation, neuroinflammation, oxidative stress, and excitotoxicity that contribute to motor neuron degeneration. The role of biomarkers is highlighted for their importance in early diagnosis and disease monitoring. Additionally, the review explores emerging therapeutic approaches, including inhibitors of protein aggregation, neuroinflammation modulators, antioxidant therapies, gene therapy, and stem cell-based treatments. The advantages and challenges of these strategies are discussed, with an emphasis on the potential for precision medicine to tailor treatments to individual patient needs. Overall, this review aims to provide a comprehensive overview of the current state of ALS research and suggest future directions for developing effective therapies.

The gut microbiome, comprising a wide range of bacteria, viruses, and fungi, plays a vital role in maintaining human health. Its composition is influenced by factors such as diet, environment, and genetics, which in turn affect the microbiomes functions in digestion, immune regulation, and metabolism. The core of these functions is the production of metabolites and signalling molecules that interact with protein receptors in the gut. These receptors, including G-protein-coupled receptors (GPCRs) and toll-like receptors (TLRs), regulate gut physiology, such as motility, secretion, and barrier integrity. The interactions between gut microbial metabolites, such as short-chain fatty acids and bile acids, and these receptors are crucial in modulating immune responses, nutrient absorption, and host metabolism. Understanding these complex interactions is essential for advancing genomic studies, as they reveal critical gene-environment interactions and epigenetic modifications mediated by the gut microbiota. By integrating microbiome and genomic data, we can explore microbiome-receptor interactions through genome-wide association studies and multi-omics approaches, making the way for personalized medicine. These insights have profound implications for health outcomes, particularly in chronic diseases like obesity, diabetes, and inflammatory bowel disease (IBD), as well as mental health disorders. Therapeutic interventions, including probiotics, prebiotics, and receptor-targeting drugs, hold promise for modulating these interactions. Future research directions focus on translating these findings into clinical practice, offering potential for targeted therapies and personalized interventions that improve health outcomes.

Food technology has a fundamental role in shaping the modern food industry, significantly influencing food quality, safety, and nutrition. This review provides a comprehensive exploration of food technology, tracing its historical evolution from early preservation methods to contemporary innovations. The core areas of food technology processing, preservation, packaging, and fortification are critically examined, highlighting their impact on nutritional value and food sustainability. The review explores into innovative technologies, such as biotechnology, that are transforming food production and addressing global challenges, including food security, sustainability, and public health. Ethical and regulatory considerations surrounding food technology are also discussed, emphasizing the need for responsible practices and robust frameworks to ensure consumer safety and environmental protection.